New Study Suggests Certain Type 2 Diabetes Drugs May Cause Pre-Cancerous Pancreatic Cell Growth
An article published by Bloomberg indicates that new research suggests that popular diabetic drugs like Januvia®, which is manufactured by pharmaceutical giant Merck & Co., may promote pre-cancerous pancreatic cell changes and proliferation. The new report from UCLA researchers follows an FDA statement earlier this month indicating that the federal agency was reviewing unpublished findings suggesting that abnormal pre-cancerous cell changes may be linked to a category of Type 2 diabetes drugs referred to as incretin mimetics, which includes Bristol-Myers Squibb Co. (BMY)’s Byetta®.
There has been concern among physicians about this type of Type 2 Diabetes drug since the FDA issued a report in 2007 that disclosed an elevated number of cases of pancreatitis among patients taking Byetta. This alert was extended to Januvia® in 2009. These warnings amplify concerns expressed in an article published in the JAMA Internal Medicine journal last month that were based on a review of insurance records and suggested this class of drugs may double the risk of pancreatitis.
In the recently released study, researchers examined the pancreases of twenty diabetics and found that among the eight receiving incretin drugs there was a forty percent increase in pancreatic cells and damaged cells according to the journal Diabetes. Eight of the patients were receiving incretin mimetics drugs with seven being treated with Merck’s Januvia® and one taking Byetta®. According to the researchers, those receiving incretin drugs exhibited “marked” proliferation of cells and cellular damage that could develop into cancer.
Merck declined to comment on the findings of the report but indicated that “an extensive nonclinical safety program” involving Byetta® did not reveal “any drug-related pancreatic tissue damage or toxicity in any species tested.”
The FDA received approximately 88 adverse event reports between October 2006 and February 2009 involving acute pancreatitis by patients taking Januvia® and Janumet®, which combines melformin and Januvia®. Some of the facts disclosed by the FDA about these adverse reports include:
- Two-thirds of the cases resulted in hospitalization.
- One in five of the patients developed pancreatitis within a month of beginning use of one of these two drugs.
- More than half of the patients’ medical conditions resolved after they discontinued use of the drugs.
- Two of the cases involved severe hemorrhagic or necrotizing pancreatitis.
Generally, a drug manufacturer may be liable for a defective pharmaceutical based on faulty design, improper manufacturing or inadequate warnings of risks associated with the drug. The FDA has not imposed labeling requirements but will presumably continue to analyze adverse event reports associated with the diabetes drug.
Our experienced Georgia personal injury attorneys at Montlick and Associates are available to provide effective legal representation to those throughout all of Georgia and the Southeast.
Why Montlick & Associates?
Choosing an experienced personal injury law firm can make all the difference in getting you the best possible outcome for your case. For over 35 years, the experienced attorneys from Montlick & Associates have been helping families in Georgia and throughout the Southeast. Montlick & Associates concentrates its practice on personal injury law, providing caring and high quality legal representation.
The firm was recently honored by the Georgia House of Representatives for its 30 years of service, with the passing of House Resolution 394, recognizing Montlick & Associates for "the outstanding accomplishments of this distinguished firm," and “for providing efficient, effective and dedicated services to the citizens of Georgia.”
The experienced Georgia personal injury attorneys at Montlick and Associates are available to provide effective legal representation to clients throughout Georgia, including rural areas in the state and across the Southeast. No matter where you are located, the attorneys at Montlick & Associates are just a phone call away, and will even come to you. Call 24 hours a day/7 days a week for your Free Consultation at 1-800-LAW-NEED (1-800-529-6333). You can also visit online at www.montlick.com and use the firm’s Free 24-hour Live Online Chat or Free Case Evaluation Form.